Evidence map›Paper›PMID 26618050›Full record

ArticleAging and disease2015

Relationship between CYP17A1 Genetic Polymorphism and Essential Hypertension in a Chinese Population.

Chuan-Fang Dai, Xiang Xie, Yi-Tong Ma, Yi-Ning Yang, Xiao-Mei Li, Zhen-Yan Fu, Fen Liu, Bang-Dang Chen, Min-Tao Gai

Open access · goldAbstract read
In one paragraph

Article in Aging and disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Association of ACE2 genetic polymorphisms with hypertension-related target organ damages in south Xinjiang.Hypertension research : official journal of the Japanese Society of Hypertension · 2019
    Article
  4. Article
  5. Article
  6. Association of CYP17A1 Genetic Polymorphisms and Susceptibility to Essential Hypertension in the Southwest Han Chinese Population.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Chuan-Fang DaiDepartment of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054 China.
Xiang XieDepartment of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054 China.
Yi-Tong MaDepartment of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054 China.
Yi-Ning YangDepartment of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054 China.
Xiao-Mei LiDepartment of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054 China.
Zhen-Yan FuDepartment of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054 China.
Fen LiuDepartment of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054 China.
Bang-Dang ChenDepartment of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054 China.
Min-Tao GaiDepartment of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054 China.
First Affiliated Hospital of Xinjiang Medical University · CNXinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The relationship between CYP17A1 genetic polymorphisms and essential hypertension (EH) remains unclear. The aim of this study was to investigate the association of CYP17A1 genetic polymorphisms with EH in Han and Uighur populations in China. A Han population including 558 people (270 EH patients and 288 controls) and a Uighur population including 473 people (181 EH patients and 292 controls) were selected. Five single-nucleotide polymorphisms (SNPs) (rs4919686, rs1004467, rs4919687, rs10786712, and rs2486758) were genotyped using real-time PCR (TaqMan). In the Uighur population, for the total and the men, rs4919686, rs4919687 and rs10786712 were found to be associated with EH (rs4919686: P≤0.02, rs4919687: P≤0.002, rs10786712: P≤0.004, respectively). The difference remained statistically significant after the multivariate adjustment (all P<0.05). The overall distributions of the haplotypes established by SNP1-SNP3, SNP1-SNP4, SNP1-SNP3-SNP5 and SNP1-SNP4-SNP5 were significantly different between the EH patients and the control subjects (for the total: P=0.013, P=0.008, P=0.032, P=0.010, for men: P<0.001, P=0.001, P=0.010, P=0.00). In the Han population, for men, rs2486758 was found to be associated with EH in a recessive model (P=0.007); the significant difference was not retained after the adjustment for the covariates (date not shown). The A allele of rs4919686 could be a susceptible genetic marker, and the T allele of rs10786712 could be a protective genetic marker of EH. The AC genotype of rs4919686, the AG genotype of rs4919687 and the TT genotype of rs10786712 could be protective genetic markers of EH.

Indexed as

case-control studyCYP17A1 geneessential hypertensionsingle nucleotide polymorphism

Identifiers

PMID26618050
PMCPMC4657820
OpenAlexW2198473206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.